Omega promo web banner
Omega promo Mobile banner

Onesource Specialty Pharma Ltd - Stock Valuation and Financial Performance

BSE: 544292 | NSE: ONESOURCE | Pharmaceuticals & Drugs | Small Cap

Place order

Onesource Specialty Share Price

 ₹2,028.30 -81.05 -3.84%
as on 20-Jun'25 16:59

DeciZen - make an informed investing decision on Onesource Specialty

Overall Rating ⓘ
Bole Toh

1. Quality

Not Good
Check detailed 10 Yrs performace

2. Valuation

Overvalued
Check 10 Yrs Valuation charts

3. Price Trend

Strong
Check Price chart

Onesource Specialty Pharma stock performance -

PE Chart Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
23,217.1 Cr.
52-wk low:
1,163.1
52-wk high:
2,249.7

Is Onesource Specialty Pharma Ltd an attractive stock to invest in?

1. Is Onesource Specialty Pharma Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Onesource Specialty Pharma Ltd is a below average quality company.

2. Is Onesource Specialty Pharma Ltd undervalued or overvalued?

The key valuation ratios of Onesource Specialty Pharma Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Onesource Specialty Pharma Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Onesource Specialty Pharma Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Onesource Specialty:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Standalone Basis P Consolidated Basis P
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Onesource Specialty Pharma Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

Mar'23Mar'24TTM
ROCE % ⓘ-23.5%-21.3%-
Value Creation
Index ⓘ		-3.1-2.9-

Growth Parameters ⓘ

Growth Parameters Colour Code Guide ⓘ

Sales ⓘ38.71721,300
Sales YoY Gr.-344.1%-
Adj EPS ⓘ-94.7-86.91.8
YoY Gr.-NA-
BVPS (₹) ⓘ194.797.2517.2
Adj Net
Profit ⓘ		-394-36120
Cash Flow from Ops. ⓘ-165-109-
Debt/CF from Ops. ⓘ-5.1-5.2-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANANA344.1%
Adj EPS ⓘNANANANA
BVPSⓘNANANA-50.1%
Share Price - - - -

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

Mar'23Mar'24TTM
Return on
Equity % ⓘ		-50-610.6
Op. Profit
Mgn % ⓘ		-391.2-47.235
Net Profit
Mgn % ⓘ		-1016.7-2101.5
Debt to
Equity ⓘ		1.11.40
Working Cap
Days ⓘ		0431155
Cash Conv.
Cycle ⓘ		097-225

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 0.60%

Sales growth is good in last 4 quarters at 288.40%

Sales growth has been subdued in last 3 years 0.00%

Debt to equity has increased versus last 3 years average to 1.44

Latest Financials - Onesource Specialty Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) 1.8 -1.6
TTM Sales (₹ Cr.) 1,300 1,445
BVPS (₹.) ⓘ 517.2 513.7
Reserves (₹ Cr.) ⓘ 5,909 5,869
P/BV ⓘ 3.92 3.95
PE ⓘ 0.00 0.00
From the Market
52 Week Low / High (₹) 1163.05 / 2249.65
All Time Low / High (₹) 1163.05 / 2249.65
Market Cap (₹ Cr.) 23,217
Equity (₹ Cr.) 11.5
Face Value (₹) 1
Industry PE ⓘ 40.7

Management X-Ray of Onesource Specialty:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *9.5820.06
* Pledged shares as % of Promoter's holding (%)

Valuation of Onesource Specialty

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Onesource Specialty

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
Standalone Basis Consolidated Basis
PARTICULARSMar'23Mar'24
Sales39172
Operating Expenses ⓘ 199259
Manufacturing Costs3738
Material Costs2271
Employee Cost 7379
Other Costs ⓘ 6872
Operating Profit ⓘ -161-88
Operating Profit Margin (%) -414.0%-50.9%
Other Income ⓘ 34
Interest ⓘ 4889
Depreciation ⓘ 6676
Exceptional Items ⓘ -158-116
Profit Before Tax ⓘ -430-365
Tax ⓘ 00
Profit After Tax -430-365
PAT Margin (%) -1,109.6%-212.0%
Adjusted EPS (₹)-107.0-91.0
Dividend Payout Ratio (%)0%0%

Balance Sheet

(All Figures are in Crores.)
Standalone Basis Consolidated Basis
PARTICULARSMar'23Mar'24

Equity and Liabilities

Shareholders Fund 781390
Share Capital ⓘ 44
Reserves ⓘ 777386
Minority Interest00
Debt529406
Long Term Debt335272
Short Term Debt194134
Trade Payables9581
Others Liabilities ⓘ 604432
Total Liabilities ⓘ 2,0081,309

Fixed Assets

Gross Block1,6331,139
Accumulated Depreciation271277
Net Fixed Assetsⓘ 1,361863
CWIP ⓘ 334188
Investmentsⓘ 520
Inventories13311
Trade Receivables455
Cash Equivalents 8060
Others Assetsⓘ 91111
Total Assets ⓘ 2,0081,309

Cash Flow

(All Figures are in Crores.)
Standalone Basis Consolidated Basis
PARTICULARSMar'23Mar'24
Cash Flow From Operating Activity ⓘ -165-109
PBT ⓘ -799-390
Adjustment ⓘ 605288
Changes in Working Capital ⓘ 19-7
Tax Paid ⓘ 110
Cash Flow From Investing Activity ⓘ -66506
Capex -42-63
Net Investments -2760
Others ⓘ 3510
Cash Flow From Financing Activityⓘ 118-384
Net Proceeds from Shares ⓘ 5650
Net Proceeds from Borrowing ⓘ -393-428
Interest Paid ⓘ -105-103
Dividend Paid ⓘ 00
Others ⓘ 52147
Net Cash Flow ⓘ -11213

Finance Ratio

Standalone Basis Consolidated Basis
PARTICULARSMar'23Mar'24
Ratios
ROE (%)-55.02-62.35
ROCE (%)-23.53-21.34
Asset Turnover Ratio0.020.1
PAT to CFO Conversion(x)N/AN/A
Working Capital Days
Receivable Days3563
Inventory Days1,255153
Payable Days1,606455

Onesource Specialty Pharma Ltd Stock News

Onesource Specialty Pharma Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Onesource Specialty on 20-Jun-2025 16:59 is ₹2,028.3.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Jun-2025 16:59 the market cap of Onesource Specialty stood at ₹23,217.1.
The latest P/E ratio of Onesource Specialty as of 20-Jun-2025 16:59 is 0.00.
The latest P/B ratio of Onesource Specialty as of 20-Jun-2025 16:59 is 3.92.
The 52-week high of Onesource Specialty is ₹2,249.7 and the 52-week low is ₹1,163.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Onesource Specialty is ₹1,300 ( Cr.) .

About Onesource Specialty Pharma Ltd

OneSource Specialty Pharma Limited, formerly known as Stelis Biopharma Limited, is India’s first specialty pharma pure-play Contract Development and Manufacturing Organization (CDMO) business. By integrating Stelis’ Biologics CDMO, SteriScience's Complex Injectables, and Strides' Soft Gelatin businesses, it is positioned to deliver exceptional services to its customers. 

Following the NCLT process and listing, OneSource Specialty Pharma will operate state-of-the-art facilities in Bengaluru, India, all approved by major regulatory bodies, including the USFDA and EU authorities. Its comprehensive solutions span across platforms and therapeutic modalities, including Biologics, Drug-device combinations, Complex Injectables, and Oral Technologies. Committed to innovation and excellence, it supports global partners in delivering life-saving products efficiently.

Business area of the company

OneSource Specialty Pharma is a multimodal specialty pharma CDMO with end-to-end capabilities across technology platforms and therapeutic modalities.


Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
SEBI Registered: Investment Adviser - INA000013323 RIA Details
Request a Call back
Refer and Earn
Partner with Us
WhatsApp +91 9860359463
besafe@moneyworks4me.com
Warning: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer: Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provides any assurance of returns to investors.
Compliance Officer:
Name: Shrikant Jagtap
Email: shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance Officer:
Name: Mukta Vaze
Email: mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email: atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
SEBI regional/local office address-
Plot No. C 4-A , G Block, Near Bank of India, Bandra Kurla Complex, Bandra East, Mumbai, Maharashtra 400051
linkedin facebook twitter youtube insta telegram
Address:
The Alchemists Ark Pvt. Ltd., B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | ODR | Investor charter | Terms & Conditions | Disclaimer | Disclosure
Data provided by Accord Fintech Pvt. Ltd.
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...